investorscraft@gmail.com

Intrinsic ValueKings Arms Yard VCT PLC (KAY.L)

Previous Close£19.00
Intrinsic Value
Upside potential
Previous Close
£19.00

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2023 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Kings Arms Yard VCT PLC is a UK-based venture capital trust (VCT) specializing in early-stage investments, primarily targeting unquoted companies and those listed on the Alternative Investment Market (AIM). The firm focuses on high-growth sectors such as information and communication technologies (ICT) and healthcare, adhering to strict investment criteria, including gross asset limits and employee thresholds. Its portfolio is diversified across equity and fixed-income securities, with a preference for long-term loans. The VCT structure provides tax-efficient returns to investors, leveraging UK government incentives for risk capital deployment. Kings Arms Yard differentiates itself by avoiding traditional financial services, property, and agricultural sectors, instead concentrating on innovative SMEs with scalable business models. Its disciplined approach ensures compliance with state-aided risk capital schemes, maximizing investor benefits while mitigating concentration risk. The trust’s niche focus on sub-£16 million companies positions it as a key player in the UK’s venture capital ecosystem, supporting entrepreneurial growth while delivering shareholder value.

Revenue Profitability And Efficiency

In FY 2023, Kings Arms Yard reported revenue of £2.1 million and net income of £2.14 million, reflecting a profitable year despite a negative operating cash flow of £1.09 million. The diluted EPS of 0.41p indicates modest earnings per share, while the absence of capital expenditures suggests a focus on portfolio management rather than infrastructure investments. The trust’s revenue model relies heavily on investment gains and dividend income from its portfolio.

Earnings Power And Capital Efficiency

The trust’s earnings are driven by its ability to identify and nurture high-potential SMEs, with a net income exceeding revenue, indicating efficient cost management. The lack of total debt underscores a conservative financial strategy, while £20.2 million in cash reserves provides liquidity for future investments. The negative operating cash flow, however, signals potential short-term liquidity constraints or reinvestment activities.

Balance Sheet And Financial Health

Kings Arms Yard maintains a robust balance sheet with £20.2 million in cash and no debt, reflecting strong financial health. The absence of leverage reduces risk, while the sizable cash position supports ongoing investment activities. The trust’s focus on unquoted and AIM-listed equities aligns with its long-term investment horizon, though liquidity risks may arise from its illiquid asset base.

Growth Trends And Dividend Policy

The trust’s dividend payout of 0.61p per share demonstrates a commitment to returning capital to shareholders, a key feature of VCTs. Growth is driven by selective investments in high-potential SMEs, though the modest market cap of £105.9 million suggests a niche scale. The focus on ICT and healthcare sectors aligns with broader market trends favoring technology and innovation.

Valuation And Market Expectations

With a market cap of £105.9 million and a beta of -0.013, Kings Arms Yard exhibits low correlation to broader market movements, typical of alternative investment vehicles. The trust’s valuation reflects its specialized portfolio and tax-advantaged structure, appealing to investors seeking exposure to early-stage UK companies with growth potential.

Strategic Advantages And Outlook

Kings Arms Yard’s strategic advantage lies in its disciplined investment criteria and tax-efficient structure, attracting risk-tolerant investors. The focus on ICT and healthcare sectors positions it well for long-term growth, though macroeconomic volatility could impact portfolio performance. The trust’s outlook remains tied to the success of its underlying investments and the stability of UK venture capital incentives.

Sources

Company filings, London Stock Exchange data

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2024202520262027202820292030203120322033203420352036203720382039204020412042204320442045204620472048

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount